Prognostic biomarkers and next generation genomic sequencing
21 May 2012
Prognostic biomarkers and next generation genomic sequencing
Primary and secondary resistance in colorectal cancer
Analysing changes in the pharmaceutical industry
Economics of treating patients
Heterogeneity of global cancer outcomes
Use of bio-banks in the EurocanPlatform
Progress of the EurocanPlatform, one year on
Update on the FP7 TRANSCAN Project
New approaches to personalised medicine
Bringing together the resources of Eastern and Western European institutes
Goals of the German Consortium for Translational Cancer Research
Recent developments in neoadjuvant therapy